GSK-1838705-A

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameGSK-1838705-A
Drug Alias NameGSK-1838705AGSK-1838705-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I receptor antagonistsAnaplastic lymphoma kinase inhibitors
TargetsInsulin-like growth factor I receptorAnaplastic lymphoma kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A